Romiset 125mcg Injection 6ml

Romiset 125mcg injection 6ml is a platelet-stimulating agent containing the active ingredient Romiplostim. It is used to treat immune primary thrombocytopenia (ITP), a condition in which the body's immune system mistakenly attacks and destroys its own platelets, resulting in low platelet counts. This drug is primarily used in adults and children aged 18 years and over with immune primary thrombocytopenia when other treatments have proven ineffective. It is prescribed for patients with ITP who have not responded adequately to immunoglobulins, corticosteroids, or splenectomy (surgical spleen removal).

Romiset 125mcg injection 6ml is contraindicated in individuals with known hypersensitivity or allergic reactions to medicines produced by DNA technology using the micro-organism Escherichia coli (E. coli).

Before receiving this injection, inform your doctor about certain medical conditions including liver problems, cancer, recent surgery, smoking habits, and use of birth control pills. These factors may impact the safety and effectiveness of the medication. Your doctor needs this information to determine whether Romiset 125mcg injection 6ml is appropriate for you or if any adjustments to your treatment plan are necessary.

During treatment with this drug, your doctor will monitor your blood tests regularly to assess for any abnormalities that may indicate bone marrow changes. Because this drug has been associated with major changes in the bone marrow, abnormalities detected will be evaluated for their significance. Your doctor will determine the appropriate course of action and may decide to continue or discontinue treatment based on findings.

Romiset 125mcg injection 6ml is not recommended for pregnant patients unless specifically indicated by your doctor. Inform your doctor if you are pregnant, suspect pregnancy, or are planning pregnancy before initiating treatment. It is not known whether this drug is present in human milk. Therefore, breastfeeding should be avoided.

Treatment of immune thrombocytopenia (ITP)

Romiset 125mcg injection 6ml works by stimulating the production of platelets in the bone marrow. It binds to and activates the thrombopoietin receptor, which promotes the development and maturation of platelets. This helps to increase the platelet count in individuals with ITP.

Romiset 125mcg injection 6ml will be administered to you by a healthcare professional in a hospital setting. It is usually administered as a subcutaneous injection (under the skin). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Loss of response Progression of Myelodysplastic syndromes Thromboembolic complications Leukemia Higher risk of blood clots Common Headache, dizziness Allergic reaction Upper respiratory tract infection Joint pain, muscle pain Indigestion Sleeping trouble Tingling or numbness of feet or hands Abdominal pain, diarrhea, indigestion Fever, cough

Since Romiset 125mcg injection 6ml affects platelet production, it's essential to take precautions to avoid injuries and bleeding. Be cautious when engaging in activities that may increase your risk of injury, and report any unusual bleeding or bruising to your physician.